Accordingly, TLR4 has been shown to be upregulated in human BC tissues [47, 48] and constitutive activation of IRAK1 and NF-kB, key downstream effectors of TLR4 signaling, has been frequently reported in TNBC [49–51]. The gene discussed is TLR4; the disease is breast cancer.